Robotic Whipple surgery shows promising outcomes, establishing benchmarks vital for surgical practice.

• Conversion rate ≤4.3%, transfusion rate ≤2.1%, and 6-month mortality ≤2.2%.
• Major complications capped at ≤23.2%, with clinically relevant pancreatic fistula and hemorrhage rates ≤23.6% and ≤12.7%, respectively.

These benchmarks can guide patient selection and enhance surgical quality.

• Higher caseload centers reported fewer pancreas-specific complications, highlighting the importance of surgical volume.